论文部分内容阅读
本品首先由日本武田制药株式会社和美国普强制药厂研制成功,1981年由普强药厂上市。国内试制成功后,药理和临床研究确认本品具有显著的安眠、镇静和抗癫癎作用。与国内现有的安定类药物相比,有服用剂量小,治疗作用强、毒副作用小、安全范围大等特点,于1984年12月通过了技术鉴定。药理作用:本品为一新型苯并二氮杂(艹卓)类
This product was first developed by Japan Takeda Pharmaceutical Co., Ltd. and the United States Puqiang Pharmaceutical Factory, 1981 by Puliang pharmaceutical listed. After the successful trial in China, pharmacological and clinical studies confirm this product has significant sleep, sedation and anti-epileptic effects. Compared with the existing domestic stability drugs, there is a small dose, strong therapeutic effect, small side effects, wide range of safety and other characteristics, in December 1984 passed the technical appraisal. Pharmacological effects: This product is a new benzodiazepine (艹 Zhuo) category